SRB Corp Increases Position in Walgreens Boots Alliance Inc (NASDAQ:WBA)

SRB Corp lifted its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 47.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,207 shares of the pharmacy operator’s stock after purchasing an additional 3,288 shares during the period. SRB Corp’s holdings in Walgreens Boots Alliance were worth $646,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in WBA. Oregon Public Employees Retirement Fund increased its stake in Walgreens Boots Alliance by 12,422.1% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 34,807,507 shares of the pharmacy operator’s stock valued at $509,000 after purchasing an additional 34,529,539 shares during the period. Norges Bank bought a new stake in Walgreens Boots Alliance in the 4th quarter valued at about $589,781,000. Boston Partners lifted its position in Walgreens Boots Alliance by 3,449.3% in the 4th quarter. Boston Partners now owns 3,973,944 shares of the pharmacy operator’s stock valued at $271,540,000 after purchasing an additional 3,861,981 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in Walgreens Boots Alliance by 263.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 3,306,439 shares of the pharmacy operator’s stock valued at $209,198,000 after purchasing an additional 2,396,640 shares during the last quarter. Finally, APG Asset Management N.V. lifted its position in Walgreens Boots Alliance by 66.2% in the 4th quarter. APG Asset Management N.V. now owns 3,740,281 shares of the pharmacy operator’s stock valued at $223,569,000 after purchasing an additional 1,489,401 shares during the last quarter. Hedge funds and other institutional investors own 61.60% of the company’s stock.

Shares of WBA traded down $0.54 during mid-day trading on Friday, hitting $52.35. The company’s stock had a trading volume of 56,686 shares, compared to its average volume of 4,438,551. The stock has a market capitalization of $48.24 billion, a P/E ratio of 8.68, a P/E/G ratio of 1.07 and a beta of 0.77. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. Walgreens Boots Alliance Inc has a fifty-two week low of $49.31 and a fifty-two week high of $86.31.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). The business had revenue of $34.53 billion during the quarter, compared to analyst estimates of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.73 EPS. As a group, equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Monday, May 20th were paid a $0.44 dividend. The ex-dividend date was Friday, May 17th. This represents a $1.76 annualized dividend and a dividend yield of 3.36%. Walgreens Boots Alliance’s dividend payout ratio is currently 29.24%.

WBA has been the topic of several recent research reports. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Thursday, February 14th. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, February 26th. Robert W. Baird cut their price objective on shares of Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating on the stock in a research report on Friday, March 1st. ValuEngine downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Friday, March 1st. Finally, UBS Group cut their price objective on shares of Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating on the stock in a research report on Monday, March 4th. Six analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $64.89.

In related news, COO Ornella Barra purchased 18,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was acquired at an average cost of $54.56 per share, for a total transaction of $982,080.00. Following the completion of the acquisition, the chief operating officer now owns 26,425 shares in the company, valued at approximately $1,441,748. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the sale, the chief accounting officer now owns 435,811 shares of the company’s stock, valued at $23,119,773.55. The disclosure for this sale can be found here. Insiders own 15.73% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by Markets Daily and is owned by of Markets Daily. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.themarketsdaily.com/2019/06/14/srb-corp-increases-position-in-walgreens-boots-alliance-inc-nasdaqwba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: What are the qualifications of a portfolio manager?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.